» Articles » PMID: 25371906

Characterization of Diabetic Neuropathy in the Zucker Diabetic Sprague-Dawley Rat: a New Animal Model for Type 2 Diabetes

Overview
Journal J Diabetes Res
Publisher Wiley
Specialty Endocrinology
Date 2014 Nov 6
PMID 25371906
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Recently a new rat model for type 2 diabetes the Zucker diabetic Sprague-Dawley (ZDSD/Pco) was created. In this study we sought to characterize the development of diabetic neuropathy in ZDSD rats using age-matched Sprague-Dawley rats as a control. Rats were examined at 34 weeks of age 12 weeks after the onset of hyperglycemia in ZDSD rats. At this time ZDSD rats were severely insulin resistant with slowing of both motor and sensory nerve conduction velocities. ZDSD rats also had fatty livers, elevated serum free fatty acids, triglycerides, and cholesterol, and elevated sciatic nerve nitrotyrosine levels. The corneas of ZDSD rats exhibited a decrease in subbasal epithelial corneal nerves and sensitivity. ZDSD rats were hypoalgesic but intraepidermal nerve fibers in the skin of the hindpaw were normal compared to Sprague-Dawley rats. However, the number of Langerhans cells was decreased. Vascular reactivity of epineurial arterioles, blood vessels that provide circulation to the sciatic nerve, to acetylcholine and calcitonin gene-related peptide was impaired in ZDSD rats. These data indicate that ZDSD rats develop many of the neural complications associated with type 2 diabetes and are a good animal model for preclinical investigations of drug development for diabetic neuropathy.

Citing Articles

8-Aminoguanine and its actions in the metabolic syndrome.

Jackson E, Gillespie D, Mi Z, Birder L, Tofovic S Sci Rep. 2024; 14(1):22652.

PMID: 39349636 PMC: 11442972. DOI: 10.1038/s41598-024-73159-4.


Resting-state MRI reveals spontaneous physiological fluctuations in the kidney and tracks diabetic nephropathy in rats.

Baldelomar E, Morozov D, Wilson L, Eldeniz C, An H, Charlton J Am J Physiol Renal Physiol. 2024; 327(1):F113-F127.

PMID: 38660712 PMC: 11390131. DOI: 10.1152/ajprenal.00423.2023.


Periodontitis promotes the progression of diabetes mellitus by enhancing autophagy.

Cai Z, Du S, Zhao N, Huang N, Yang K, Qi L Heliyon. 2024; 10(2):e24366.

PMID: 38288023 PMC: 10823111. DOI: 10.1016/j.heliyon.2024.e24366.


Semaphorin 3A delivered by a rapidly polymerizing click hydrogel overcomes impaired implant osseointegration in a rat type 2 diabetes model.

Deng J, Cohen D, Sabalewski E, Van Duyn C, Wilson D, Schwartz Z Acta Biomater. 2022; 157:236-251.

PMID: 36435442 PMC: 10007856. DOI: 10.1016/j.actbio.2022.11.030.


Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions.

Hossain M, Kendig M, Letton M, Morris M, Arnold R Diabetes Metab J. 2022; 46(2):198-221.

PMID: 35385634 PMC: 8987683. DOI: 10.4093/dmj.2021.0347.


References
1.
Davis J, Cain J, Banz W, Peterson R . Age-Related Differences in Response to High-Fat Feeding on Adipose Tissue and Metabolic Profile in ZDSD Rats. ISRN Obes. 2014; 2013:584547. PMC: 3901986. DOI: 10.1155/2013/584547. View

2.
Coppey L, Holmes A, Davidson E, Yorek M . Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic rat. J Nutr Metab. 2012; 2012:950517. PMC: 3439986. DOI: 10.1155/2012/950517. View

3.
Davidson E, Coppey L, Kleinschmidt T, Oltman C, Yorek M . Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688. Exp Diabetes Res. 2009; 2009:912327. PMC: 2695958. DOI: 10.1155/2009/912327. View

4.
Clark J, Palmer C, Shaw W . The diabetic Zucker fatty rat. Proc Soc Exp Biol Med. 1983; 173(1):68-75. DOI: 10.3181/00379727-173-41611. View

5.
Oltman C, Kleinschmidt T, Davidson E, Coppey L, Lund D, Yorek M . Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes. Vascul Pharmacol. 2008; 48(1):47-53. DOI: 10.1016/j.vph.2007.11.005. View